DEF 14AThe Ballot
Theravance Biopharma, Inc. files DEF 14A
Filed Mar 22, 2021 · 5y ago · Accession 0001104659-21-039784
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- DEF 14A
- Filing date
- Mar 22, 2021
- Report date
- Apr 27, 2021
- Document
- tm212357-1_def14a.htm
- Size
- 3.0 MB